Working Groups      
         
  Within EAMG, specialised working groups are established for the purpose of creating an environment for discussions and exchanges of ideas in relation to the pharmaceutical regulatory developments in Europe. The focus is directed towards optimising clinical issues and clinical development programs fulfilling the up-to-date criteria for documentation as well as interpretation of the guidelines and regulations created by the European Medicine Agency. EAMG as an organisation has the opportunity to be heard, comment and influence future guidelines in accordance with the official rules and regulations for these hearing processes.  
         
 

Working Group Clinical Issues

Annemie Narkus
Allergopharma

Angelika Sager
Laboratorios LETI

Olivier de Beaumont
Stallergènes

Karl-Jürgen Drachenberg
Allergy Therapeutics)

Paolo Falagiani
Lofarma

Huub Kleinjans
HAL Allergy

Martin Rud Pedersen
ALK-Abelló

Lars Jacobsen
Secretary, EAMG

 

Working Group Regulatory Affairs

Paolo Falagiani
Lofarma

Carmen Garcia
Laboratorios LETI

Marion Kreitz
Allergy Therapeutics

Birgitte Kristensen
ALK-Abelló

Rudolf Radetzky
Allergopharma

Tran Xuan Thao
Stallergènes

Willem Jan Veldhuizen
HAL Allergy

Lars Jacobsen
Secretary, EAMG